相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Gene fusion involving the insulin-like growth factor 1 receptor in an ALK-negative inflammatory myofibroblastic tumour
Giuseppe Piarulli et al.
HISTOPATHOLOGY (2019)
Identification of a novel BOC-PLAG1 fusion gene in a case of lipoblastoma
Yoshihiro Nitta et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex
Malin Linden et al.
EMBO REPORTS (2019)
TRK Fusion Cancers in Children: A Clinical Review and Recommendations for Screening
Catherine M. Albert et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
Robert M. Samstein et al.
NATURE GENETICS (2019)
Involvement of platelet-derived growth factor ligands and receptors in tumorigenesis
C. -H. Heldin et al.
JOURNAL OF INTERNAL MEDICINE (2018)
ETV6-NTRK3 in congenital mesoblastic nephroma: A report of the SIOP/GPOH nephroblastoma study
Christian Vokuhl et al.
PEDIATRIC BLOOD & CANCER (2018)
The Role of Molecular Testing in the Differential Diagnosis of Salivary Gland Carcinomas
Alena Skalova et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2018)
Insulin-like growth factor 1 receptor stabilizes the ETV6-NTRK3 chimeric oncoprotein by blocking its KPC1/Rnf123-mediated proteasomal degradation
Cristina E. Tognon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Oncogenic fusion proteins adopt the insulin-like growth factor signaling pathway
Haim Werner et al.
MOLECULAR CANCER (2018)
A Myc enhancer cluster regulates normal and leukaemic haematopoietic stem cell hierarchies
Carsten Bahr et al.
NATURE (2018)
NTRK fusion-positive cancers and TRK inhibitor therapy
Emiliano Cocco et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
A Phase I Clinical Trial and Independent Patient-Derived Xenograft Study of Combined Targeted Treatment with Dacomitinib and Figitumumab in Advanced Solid Tumors
Emiliano Calvo et al.
CLINICAL CANCER RESEARCH (2017)
Smarca4 ATPase mutations disrupt direct eviction of PRC1 from chromatin
Benjamin Z. Stanton et al.
NATURE GENETICS (2017)
Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors
Renata Ferrarotto et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Targeting the Oncogenic Transcriptional Regulator MYB in Adenoid Cystic Carcinoma by Inhibition of IGF1R/AKT Signaling
Mattias K. Andersson et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Integrative clinical genomics of metastatic cancer
Dan R. Robinson et al.
NATURE (2017)
DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma
Nathan C. Sheffield et al.
NATURE MEDICINE (2017)
Multi-dimensional genomic analysis of myoepithelial carcinoma identifies prevalent oncogenic gene fusions
Martin G. Dalin et al.
NATURE COMMUNICATIONS (2017)
Targeting the Oncogenic Transcriptional Regulator MYB in Adenoid Cystic Carcinoma by Inhibition of IGF1R/AKT Signaling
Mattias K. Andersson et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Nuclear Factor I/B: A Master Regulator of Cell Differentiation with Paradoxical Roles in Cancer
Daiana D. Becker-Santos et al.
EBIOMEDICINE (2017)
FUS-DDIT3 Fusion Protein-Driven IGF-IR Signaling is a Therapeutic Target in Myxoid Liposarcoma
Marcel Trautmann et al.
CLINICAL CANCER RESEARCH (2017)
Acute Promyelocytic Leukemia: A Paradigm for Oncoprotein-Targeted Cure
Hugues de The et al.
CANCER CELL (2017)
Cancer-Specific Retargeting of BAF Complexes by a Prion-like Domain
Gaylor Boulay et al.
CELL (2017)
Clinical and Morphologic Features of ETV6-NTRK3 Translocated Papillary Thyroid Carcinoma in an Adult Population Without Radiation Exposure
Raja R. Seethala et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2017)
Emerging role of PLAG1 as a regulator of growth and reproduction
Almas R. Juma et al.
JOURNAL OF ENDOCRINOLOGY (2016)
Identification of Targetable Kinase Alterations in Patients with Colorectal Carcinoma That are Preferentially Associated with Wild-Type RAS/RAF
Jaclyn F. Hechtman et al.
MOLECULAR CANCER RESEARCH (2016)
ETV6-NTRK3 Is Expressed in a Subset of ALK-Negative Inflammatory Myofibroblastic Tumors
Ali H. Alassiri et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma
Yotam Drier et al.
NATURE GENETICS (2016)
The landscape of gene fusions and somatic mutations in salivary gland neoplasms - Implications for diagnosis and therapy
Mattias K. Andersson et al.
ORAL ONCOLOGY (2016)
A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma
Peter M. Anderson et al.
PEDIATRIC BLOOD & CANCER (2016)
EGFR and EML4-ALK Updated Therapies in Non-Small Cell Lung Cancer
Ramon Andrade de Mello et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2016)
Pioneer factors govern super-enhancer dynamics in stem cell plasticity and lineage choice
Rene C. Adam et al.
NATURE (2015)
Epigenome Mapping Reveals Distinct Modes of Gene Regulation and Widespread Enhancer Reprogramming by the Oncogenic Fusion Protein EWS-FLI1
Eleni M. Tomazou et al.
CELL REPORTS (2015)
Landscape of gene fusions in epithelial cancers: seq and ye shall find
Chandan Kumar-Sinha et al.
GENOME MEDICINE (2015)
The emerging complexity of gene fusions in cancer
Fredrik Mertens et al.
NATURE REVIEWS CANCER (2015)
A Phase 2 Trial of R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor-1 Receptor (IGF-1R), in Patients With Recurrent or Refractory Rhabdomyosarcoma, Osteosarcoma, Synovial Sarcoma, and Other Soft Tissue Sarcomas Results of a Sarcoma Alliance for Research Through Collaboration Study
Alberto S. Pappo et al.
CANCER (2014)
EWS-FLI1 Utilizes Divergent Chromatin Remodeling Mechanisms to Directly Activate or Repress Enhancer Elements in Ewing Sarcoma
Nicolo Riggi et al.
CANCER CELL (2014)
Phase 1b study of safety, tolerability and efficacy of R1507, a monoclonal antibody to IGF-1R in combination with multiple standard oncology regimens in patients with advanced solid malignancies
Daruka Mahadevan et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
Down-regulation of IGFBP2 is associated with resistance to IGF1R therapy in rhabdomyosarcoma
Zhigang Kang et al.
CANCER RESEARCH (2014)
Identification of COL3A1 and RAB2A as Novel Translocation Partner Genes of PLAG1 in Lipoblastoma
Hideki Yoshida et al.
GENES CHROMOSOMES & CANCER (2014)
The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma
Gang Wu et al.
NATURE GENETICS (2014)
Phase 2 Trial of Cixutumumab in Children, Adolescents, and Young Adults With Refractory Solid Tumors: A Report From the Children's Oncology Group
Brenda Weigel et al.
PEDIATRIC BLOOD & CANCER (2014)
Normal and Functional TP53 in Genetically Stable Myxoid/Round Cell Liposarcoma
Anders Stahlberg et al.
PLOS ONE (2014)
An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element
Marc R. Mansour et al.
SCIENCE (2014)
Drugging the undruggable: Transcription therapy for cancer
Chunhong Yan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2013)
Targeting transcription factors: promising new strategies for cancer therapy
Jennifer E. Yeh et al.
CURRENT OPINION IN ONCOLOGY (2013)
Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: a multicentre, open-label, phase 2 trial
Gary K. Schwartz et al.
LANCET ONCOLOGY (2013)
Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy
Cigall Kadoch et al.
NATURE GENETICS (2013)
Insulin Growth Factor-Receptor (IGF-1R) Antibody Cixutumumab Combined with the mTOR Inhibitor Temsirolimus in Patients with Refractory Ewing's Sarcoma Family Tumors
Aung Naing et al.
CLINICAL CANCER RESEARCH (2012)
Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapy
Cristina E. Tognon et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
Management of salivary gland tumors
Guy Andry et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2012)
Prioritizing Phase I Treatment Options Through Preclinical Testing on Personalized Tumorgraft
M. Pia Morelli et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Phase II Study of Ganitumab, a Fully Human Anti-Type-1 Insulin-Like Growth Factor Receptor Antibody, in Patients With Metastatic Ewing Family Tumors or Desmoplastic Small Round Cell Tumors
William D. Tap et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Involvement of the PI3K/Akt pathway in myxoid/round cell liposarcoma
Elizabeth G. Demicco et al.
MODERN PATHOLOGY (2012)
IGFBP3 impedes aggressive growth of pediatric liver cancer and is epigenetically silenced in vascular invasive and metastatic tumors
Ivonne Regel et al.
MOLECULAR CANCER (2012)
A tripartite complex composed of ETV6-NTRK3, IRS1 and IGF1R is required for ETV6-NTRK3-mediated membrane localization and transformation
C. E. Tognon et al.
ONCOGENE (2012)
Gene Expression Responses to FUS, EWS, and TAF15 Reduction and Stress Granule Sequestration Analyses Identifies FET-Protein Non-Redundant Functions
Jenny Blechingberg et al.
PLOS ONE (2012)
The insulin and insulin-like growth factor receptor family in neoplasia: an update
Michael Pollak
NATURE REVIEWS CANCER (2012)
ETV6-NTRK3-Mediated Breast Epithelial Cell Transformation Is Blocked by Targeting the IGF1R Signaling Pathway
Cristina E. Tognon et al.
CANCER RESEARCH (2011)
Combination mTOR and IGF-1R Inhibition: Phase I Trial of Everolimus and Figitumumab in Patients with Advanced Sarcomas and Other Solid Tumors
Richard Quek et al.
CLINICAL CANCER RESEARCH (2011)
R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research Through Collaboration Study
Alberto S. Pappo et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Preliminary Efficacy of the Anti-Insulin-Like Growth Factor Type 1 Receptor Antibody Figitumumab in Patients With Refractory Ewing Sarcoma
Heribert Juergens et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms
Louis B. Brill et al.
MODERN PATHOLOGY (2011)
Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review
Scott A. Laurie et al.
LANCET ONCOLOGY (2011)
ALK Inhibition for Non-Small Cell Lung Cancer: From Discovery to Therapy in Record Time
David E. Gerber et al.
CANCER CELL (2010)
Genome-Wide Identification of PAX3-FKHR Binding Sites in Rhabdomyosarcoma Reveals Candidate Target Genes Important for Development and Cancer
Liang Cao et al.
CANCER RESEARCH (2010)
Oncogenic gene fusions in epithelial carcinomas
John R. Prensner et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2009)
Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck
Marta Persson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Translation of the Philadelphia chromosome into therapy for CML
Brian J. Druker
BLOOD (2008)
The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress response
Mattias K. Andersson et al.
BMC CELL BIOLOGY (2008)
Chromosomal patterns in a benign human neoplasm, the mixed salivary gland tumour
JOACHIM MARK et al.
HEREDITAS (2008)
MYB function in normal and cancer cells
Robert G. Ramsay et al.
NATURE REVIEWS CANCER (2008)
A novel EWS-WT1 gene fusion product in desmoplastic small round cell tumor is a potent transactivator of the insulin-like growth factor-I receptor (IGF-IR) gene
Haim Werner et al.
CANCER LETTERS (2007)
Sarcomas: genetics, signalling, and cellular origins. Part I: The fellowship of TET
N. Riggi et al.
JOURNAL OF PATHOLOGY (2007)
The impact of translocations and gene fusions on cancer causation
Felix Mitelman et al.
NATURE REVIEWS CANCER (2007)
Expression of the FUS-CHOP fusion protein in primary mesenchymal progenitor cells gives rise to a model of myxoid liposarcoma
Nicolo Riggi et al.
CANCER RESEARCH (2006)
The myxoid/round cell liposarcoma fusion oncogene FUS-DDIT3 and the normal DDIT3 induce a liposarcoma phenotype in transfected human fibrosarcoma cells
K Engström et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
The insulin-like growth factor I receptor is required for Akt activation and suppression of anoikis in cells transformed by the ETV6-NTRK3 chimeric tyrosine kinase
MJ Martin et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Development of Ewing's sarcoma from primary bone marrow-derived mesenchymal progenitor cells
N Riggi et al.
CANCER RESEARCH (2005)
Amplification and overexpression of the IGF2 regulator PL4G1 in hepatoblastoma
A Zatkova et al.
GENES CHROMOSOMES & CANCER (2004)
EWS/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3
A Prieur et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
WT1-p53 interactions in insulin-like growth factor-I receptor gene regulation
G Idelman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma
C Tognon et al.
CANCER CELL (2002)
Roles of the NFI/CTF gene family in transcription and development
RM Gronostajski
GENE (2000)
分享论文
